SNA-120

DRUG2 trials

Sponsors

Sienna Biopharmaceuticals

Conditions

PruritusPsoriasisPsoriasis Vulgaris

Phase 2

Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris

CompletedNCT03322137

Sienna BiopharmaceuticalsPruritus, Psoriasis Vulgaris

Start: 2017-10-10End: 2018-10-22Updated: 2019-02-08

Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene

CompletedNCT03448081

Sienna BiopharmaceuticalsPruritus, Psoriasis

Start: 2018-02-12End: 2018-12-10Updated: 2019-02-08